Fulcrum Therapeutics Inc
FULC6.740USD
-0.090-1.32%
交易中 （美東）報價延遲15分鐘
364.58M總市值
虧損本益比TTM
關於 Fulcrum Therapeutics Inc 公司
Fulcrum Therapeutics, Inc. 是一家臨牀階段的生物製藥公司。該公司專注於改善在醫療需求尚未得到滿足的領域患有遺傳性罕見病的患者的生活。該公司的臨牀候選產品 losmapimod 是爲治療面肩肱型肌營養不良症 (FSHD) 而開發的。其另一個臨牀候選產品是 FTX-6058，用於治療某些血紅蛋白病，包括鐮狀細胞病 (SCD)。除了產品候選開發外，該公司還開發了一種藥物發現方法，用於系統地識別和驗證可能調節基因表達以治療已知的遺傳性罕見病根源的細胞藥物靶點。該公司開發了 pociredir，旨在提高胎兒血紅蛋白 (HbF) 水平，用於治療 SCD 患者。
公司簡介
公司代碼FULC
公司名稱Fulcrum Therapeutics Inc
上市日期Jul 18, 2019
CEOMr. Alex C. Sapir
員工數量45
證券類型Ordinary Share
年結日Jul 18
公司地址26 Landsdowne Street
城市CAMBRIDGE
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編02139
電話16176518851
網址https://www.fulcrumtx.com/
公司代碼FULC
上市日期Jul 18, 2019
CEOMr. Alex C. Sapir
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Alan Ezekowitz, M.D., Ph.D.
Dr. Alan Ezekowitz, M.D., Ph.D.
Independent Director
Independent Director
28.93K
--
Mr. Curtis Gale Oltmans, J.D.
Mr. Curtis Gale Oltmans, J.D.
Chief Legal Officer
Chief Legal Officer
13.27K
+36.66%
Mr. Colin Hill
Mr. Colin Hill
Independent Director
Independent Director
--
--
Mr. Alex C. Sapir
Mr. Alex C. Sapir
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Kate Haviland
Ms. Kate Haviland
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. James Arthur (Jim) Geraghty, J.D.
Mr. James Arthur (Jim) Geraghty, J.D.
Independent Director
Independent Director
--
--
Dr. Robert J. Gould, Ph.D.
Dr. Robert J. Gould, Ph.D.
Independent Director
Independent Director
--
--
Mr. Alan A. Musso, CPA
Mr. Alan A. Musso, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Sonja L. Banks
Ms. Sonja L. Banks
Independent Director
Independent Director
--
--
Ms. Rachel King
Ms. Rachel King
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Alan Ezekowitz, M.D., Ph.D.
Dr. Alan Ezekowitz, M.D., Ph.D.
Independent Director
Independent Director
28.93K
--
Mr. Curtis Gale Oltmans, J.D.
Mr. Curtis Gale Oltmans, J.D.
Chief Legal Officer
Chief Legal Officer
13.27K
+36.66%
Mr. Colin Hill
Mr. Colin Hill
Independent Director
Independent Director
--
--
Mr. Alex C. Sapir
Mr. Alex C. Sapir
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Kate Haviland
Ms. Kate Haviland
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. James Arthur (Jim) Geraghty, J.D.
Mr. James Arthur (Jim) Geraghty, J.D.
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
RA Capital Management, LP
18.91%
TCG Crossover Management, LLC
9.71%
Suvretta Capital Management, LLC
9.37%
Nantahala Capital Management, LLC
8.92%
BlackRock Institutional Trust Company, N.A.
7.27%
Other
45.83%
持股股東
持股股東
佔比
RA Capital Management, LP
18.91%
TCG Crossover Management, LLC
9.71%
Suvretta Capital Management, LLC
9.37%
Nantahala Capital Management, LLC
8.92%
BlackRock Institutional Trust Company, N.A.
7.27%
Other
45.83%
股東類型
持股股東
佔比
Hedge Fund
32.85%
Investment Advisor
28.20%
Venture Capital
19.44%
Investment Advisor/Hedge Fund
12.61%
Research Firm
2.00%
Individual Investor
1.84%
Family Office
0.53%
Bank and Trust
0.36%
Pension Fund
0.20%
Other
1.94%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
309
52.59M
97.22%
-27.74M
2025Q1
331
52.80M
97.81%
-30.83M
2024Q4
337
53.60M
99.20%
-30.15M
2024Q3
332
56.49M
90.93%
-11.78M
2024Q2
311
66.33M
106.97%
-3.71M
2024Q1
311
61.90M
100.17%
-9.69M
2023Q4
303
62.48M
101.12%
-7.74M
2023Q3
308
58.43M
94.63%
-12.63M
2023Q2
308
57.40M
93.06%
-16.00M
2023Q1
306
63.64M
104.83%
-2.07M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
RA Capital Management, LP
10.23M
18.95%
--
--
Mar 31, 2025
TCG Crossover Management, LLC
5.25M
9.73%
--
--
Mar 31, 2025
Suvretta Capital Management, LLC
5.07M
9.39%
+1.73M
+51.79%
Mar 31, 2025
Nantahala Capital Management, LLC
4.82M
8.93%
+42.98K
+0.90%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.93M
7.29%
-431.07K
-9.88%
Mar 31, 2025
The Vanguard Group, Inc.
3.22M
5.97%
-29.23K
-0.90%
Mar 31, 2025
Adage Capital Management, L.P.
3.00M
5.56%
--
--
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.41M
2.61%
-11.64K
-0.82%
Mar 31, 2025
State Street Global Advisors (US)
1.25M
2.32%
+7.12K
+0.57%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.23M
2.28%
-63.14K
-4.88%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Neuroscience and Healthcare ETF
0.82%
Simplify Health Care ETF
0.39%
Invesco Dorsey Wright SmallCap Momentum ETF
0.38%
iShares Micro-Cap ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.07%
Avantis US Small Cap Equity ETF
0.05%
iShares Russell 2000 Value ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
查看更多
iShares Neuroscience and Healthcare ETF
佔比0.82%
Simplify Health Care ETF
佔比0.39%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0.38%
iShares Micro-Cap ETF
佔比0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.07%
Avantis US Small Cap Equity ETF
佔比0.05%
iShares Russell 2000 Value ETF
佔比0.03%
Global X Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
